Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment-Reference-Cited by-同舟云学术

Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment

Published:2006-04-19 Issue:9 Volume:14 Page:901-909
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Schwenkglenks Matthias,Jackisch Christian,Constenla Manuel,Kerger Joseph N.,Paridaens Robert,Auerbach Leo,Bosly André,Pettengell Ruth,Szucs Thomas D.,Leonard Robert

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-006-0034-9.pdf

Reference27 articles.

1. Balducci L (2003) Myelosuppression and its consequences in elderly patients with cancer. Oncology (Huntingt) 17:27–32

2. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C (1995) Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med 332:901–906

3. Budman DR, Berry DA, Cirrincione CT et al (1998) Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B. J Natl Cancer Inst 90:1205–1211

4. Chang J (2000) Chemotherapy dose reduction and delay in clinical practice: evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer. Eur J Cancer 36(Suppl 1):S11–S14

5. Citron ML, Berry DA, Cirrincione C et al (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21:1431–1439

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer;The Oncologist;2024-09-07

2. Biological sex and chemotherapy treatment delays in patients with colorectal cancer;Colorectal Cancer;2024-06-07

3. Palliative Care for Gastrointestinal Cancer Patients. I-2. Management of Treatment-Related Adverse Events;Gastrointestinal Cancer;2023

4. Impact of baseline telomere length on survival and chemotherapy related toxicity in breast cancer patients receiving (neo)adjuvant anthracycline containing chemotherapy;Translational Oncology;2022-12

5. Incidence, Management and Predictors of Chemotherapy-Induced Neutropenia among Adult Solid Cancer Patients at the University of Gondar Comprehensive and Specialized Hospital: A Retrospective Follow-up Study;2022-10-12